Track topics on Twitter Track topics that are important to you
One week after the U.S. Food and Drug Administration approved Amgen’s Evenity, the California-based company has set the list price for the medication at $21,900.
Original Article: Amgen Sets Annual List Price for Osteoporosis Drug Evenity at $21,900NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...